Evidence map›Paper›PMID 35721954›Full record

ArticleACS omega2022

Catalytic Synthesis of 5-Fluoro-2-oxazolines: Using BF

Hongli Chai, Xiang Zhen, Xueqing Wang, Liang Qi, Yuji Qin, Jijun Xue, Zhaoqing Xu, Hongrui Zhang, Weiwei Zhu

Abstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Synthesis of 2-Oxazolines fromMolecules (Basel, Switzerland) · 2025
    Review
  2. Divergent role of PIDA and PIFA in the AlXBeilstein journal of organic chemistry · 2024
    Article
  3. Hypervalent iodine-mediated intramolecular alkene halocyclisation.Beilstein journal of organic chemistry · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hongli ChaiKey Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou 730000, China.
Xiang ZhenKey Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou 730000, China.
Xueqing WangDepartment of Pharmacy, College of Life Sciences, China Jiliang University, Hangzhou 310018, China.
Liang QiDepartment of Pharmacy, College of Life Sciences, China Jiliang University, Hangzhou 310018, China.
Yuji QinSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
Jijun XueKey Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou 730000, China.
Zhaoqing XuKey Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou 730000, China.ORCID https://orcid.org/0000-0001-7663-6249
Hongrui ZhangKey Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Lanzhou University, Lanzhou 730000, China.
Weiwei ZhuSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.ORCID https://orcid.org/0000-0002-1448-7708

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypervalent iodine catalyst-catalyzed nucleophilic fluorination of unsaturated amides using BF

Identifiers

PMID35721954
PMCPMC9202255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.